Pietro Lupetti Selected Research

Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)

1/2022	Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
1/2019	Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria.
7/2017	Cytoskeleton Aberrations in Alkaptonuric Chondrocytes.
1/2017	Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
9/2015	Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
9/2015	Amyloidosis in alkaptonuria.
9/2014	Diagnosis of secondary amyloidosis in alkaptonuria.
1/2014	Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.
11/2012	Alkaptonuria is a novel human secondary amyloidogenic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Lupetti Research Topics

Disease

10	Alkaptonuria 01/2022 - 11/2012
6	Amyloidosis 07/2017 - 01/2011
3	Infections 01/2020 - 01/2017
3	Ochronosis 01/2019 - 01/2014
3	Neoplasms (Cancer) 03/2018 - 01/2016
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 07/2017
2	Cysts 02/2015 - 01/2009
1	Idiopathic Pulmonary Fibrosis 05/2021
1	Inflammation (Inflammations) 07/2017
1	Cross Infection (Nosocomial Infection) 01/2017
1	Retinal Degeneration 02/2015
1	Situs Inversus 02/2015
1	Ciliopathies 02/2015
1	Amyloid Plaque 01/2014
1	Rheumatoid Arthritis 01/2014
1	Rupture 08/2013
1	Parkinson Disease (Parkinson's Disease) 11/2012
1	Rare Diseases (Rare Disease) 11/2012
1	Heart Failure 01/2011

Drug/Important Bio-Agent (IBA)

9	Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA 01/2022 - 11/2012
8	Homogentisic AcidIBA 01/2022 - 11/2012
3	EnzymesIBA 01/2022 - 02/2017
3	Peptides (Polypeptides)IBA 01/2020 - 01/2016
3	Melanins (Melanin)IBA 01/2019 - 11/2012
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2017 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 02/2017 - 02/2015
3	Amyloid (Amyloid Fibrils)IBA 02/2017 - 01/2011
2	Colistin (Coly-Mycin)FDA Link 10/2017 - 01/2017
2	Congo RedIBA 01/2014 - 11/2012
1	ProteomeIBA 05/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	PolymersIBA 01/2019
1	Antimicrobial PeptidesIBA 10/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	quinone (benzoquinone)IBA 07/2017
1	Acetic Acid (Vinegar)FDA LinkGeneric 07/2017
1	LectinsIBA 04/2017
1	carbapenemaseIBA 01/2017
1	Polysaccharides (Glycans)IBA 01/2016
1	GlycosaminoglycansIBA 01/2016
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2016
1	CytokinesIBA 01/2014
1	LipidsIBA 01/2014
1	Sucrose (Saccharose)IBA 08/2013
1	AA amyloidosisIBA 11/2012
1	Methotrexate (Mexate)FDA LinkGeneric 11/2012
1	Atrial Natriuretic Factor (ANF)IBA 01/2011

Therapy/Procedure

1	Quantum Dots (Quantum Dot) 03/2018
1	Precision Medicine 03/2018
1	Lasers (Laser) 04/2017
1	Therapeutics 11/2012
1	Transjugular Intrahepatic Portasystemic Shunt 01/2009